You are here

Brukinsa

ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice

ASH: AstraZeneca's Calquence, BeiGene's Brukinsa turn heads with new data, putting Imbruvica on notice

Fierce Pharma

Flag link:

Important catalysts approach for smaller biotechs

Important catalysts approach for smaller biotechs

EP Vantage

Turning Point Therapeutics

Intra-Cellular Therapies

clinical trials

Flag link:

3 Blockbuster Cancer Drug Launches to Watch in 2020

3 Blockbuster Cancer Drug Launches to Watch in 2020

Motley Fool

Seattle Genetics

Flag link:

5 New Drug Approvals the FDA Gave Top Priority

5 New Drug Approvals the FDA Gave Top Priority

Motley Fool

Global Blood Therapeutics

Vertex Pharmaceuticals

Flag link:

FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates

FDA Approves 5 New Costly Drugs Well Ahead of PDUFA Dates

RAPS.org

Vertex Pharmaceuticals

Global Blood Therapeutics

Flag link:

China's BeiGene gets FDA approval for drug to treat rare form of lymphoma

China's BeiGene gets FDA approval for drug to treat rare form of lymphoma

Yahoo/Reuters

mantle cell lymphoma

Flag link: